Lactoferrin - A multifunctional protein with antimicrobial properties

Molecular Immunology

Volumn 40, Issue 7, 2003, Pages 395-405

  Farnaud, Sebastien ^a   Evans, Robert W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antimicrobials; Cationic peptides; Iron; Lactoferricin; Lactoferrin

Indexed keywords

IRON; IRON BINDING PROTEIN; LACTOFERRICIN; LACTOFERRIN; PEPTIDE DERIVATIVE; TRANSFERRIN;

ACTINOBACILLUS PLEUROPNEUMONIAE; AMINO ACID SEQUENCE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BORDETELLA PERTUSSIS; DRUG PROTEIN BINDING; EIMERIA; ESCHERICHIA COLI; FUNGICIDAL ACTIVITY; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI; HUMAN; IMMUNOBIOLOGY; IMMUNOMODULATION; IRON DEPLETION; IRON TRANSPORT; LEGIONELLA PNEUMOPHILA; NEISSERIA MENINGITIDIS; NONHUMAN; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY; STREPTOCOCCUS MUTANS; TOXOPLASMA GONDII; TRICHOMONAS FOETUS; VIBRIO CHOLERAE;

NEGIBACTERIA;

EID: 0141918811     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(03)00152-4     Document Type: Review

References (83)

1. Ames G.F., Spudich E.N., Nikaido H. Protein composition of the outer membrane of Salmonella typhimurium: effect of lipopolysaccharide mutations. J. Bacteriol. 117:1974;406-416.
2. Anderson B.F., Baker H.M., Dodson E.J., Norris G.E., Rumball S.V., Waters J.M., Baker E.N. Structure of human lactoferrin at 3.2-Å resolution. Proc. Natl. Acad. Sci. U.S.A. 84:1987;1769-1773.
3. Anderson B.F., Baker H.M., Norris G.E., Rice D.W., Baker E.N. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 Å resolution. J. Mol. Biol. 209:1989;711-734.
4. Appelmelk B.J., An Y.-Q., Geerts M., Thijs B.G., de Boer H.A., MacLaren D.M., de Graaff J., Nuijens J.H. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62:1994;2628-2632.
5. Arnold R.R., Cole R.M., McGhee J.R. A bactericidal effect for human lactoferrin. Science (Washington, DC). 197:1977;263-265.
6. Arnold R.R., Brewer M., Gauthier J.J. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect. Immun. 28:1980;893-898.
7. Arnold R.R., Russell J.E., Champion W.J., Gautheir J.J. Bactericidal activity of human lactoferrin: influence of physical conditions and metabolic state of the target microorganism. Infect. Immun. 32:1981;655-660.
8. Baker E.N., Baker H.M., Kidd R.D. Lactoferrin and transferrin: functional variations on a common structural framework. Biochem. Cell Biol. 80:2002;27-34.
9. Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K., Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta. 1121:1992;130-136.
10. Bellamy W., Takase M., Wakabayashi H., Kawase K., Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 73:1992;472-479.
11. Bellamy W.R., Wakabayashi H., Takase M., Shimamura S., Tomita M. Role of cell-binding in the antibacterial mechanism of lactoferricin B. J. Appl. Microbiol. 75:1993;478-484.
12. Bevins C. Antimicrobial peptides as agents of mucosal immunity. Ciba Found. Symp. 186:1994;250-269.
13. Blondelle S.E., Takahashi E., Dinh K.T., Houghten R.A. The antimicrobial activity of hexapeptides derived from synthetic combinatorial libraries. J. Appl. Bacteriol. 78:1995;39-46.
14. Boman H.G. Peptide antibiotics and their role in innate immmunity. Ann. Rev. Immun. 13:1995;61-92.
15. Bortner C.A., Miller R.D., Arnold R.R. Bactericidal effect of lactoferrin on Legionella pneumophila. Infect. Immun. 51:1986;373-377.
16. Bortner C.A., Arnold R.R., Miller R.D. Bactericidal effect of lactoferrin on Legionella pneumophila: effect of the physiological state of the organism. Can. J. Microbiol. 35:1989;1048-1051.
17. Brock J.H. The physiology of lactoferrin. Biochem. Cell Biol. 80:2002;1-6.
18. Chapple D.S., Mason D.J., Joannou C.L., Odell E.W., Gant V., Evans R.W. Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111. Infect. Immun. 66:1998;2434-2440.
19. Cirioni O., Giacometti A., Barchiesi F., Scalise G. Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline. J. Antimicrob. Chemother. 46:2000;577-582.
20. Crouch S.P., Slater K.J., Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood. 80:1992;235-240.
21. Elass-Rochard E., Roseanu A., Legrand D., Trif M., Salmon V., Motas C., Montreuil J., Spik G. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J. 312:1995;839-845.
22. Ellison R.T. III, Giehl T.J. Killing of Gram negative bacteria by lactoferin and lysozyme. J. Clin. Invest. 88:1991;1080-1091.
23. Ellison R.T. III, Giehl T.J., LaForce F.M. Damage of the outer membrane of enteric Gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 56:1988;2774-2781.
24. 2+. J. Gen. Microbiol. 136:1990;1437-1446.
25. Esposito J.J., Obljeski J.F. Enterovirus type 70 virion and intracellular proteins. J. Virol. 18. 1976;1160-1162.
26. Evans R.W., Oakhill J.S. Transferrin-mediated iron acquisition by pathogenic Neisseria. Biochem. Soc. Trans. 30:2002;705-707.
27. Gazit E., Lee W.J., Brey P.T., Shai Y. Mode of action of the antimicrobial cecropin B2: a spectrofluorometric study. Biochemistry. 33:1994;10681-10692.
28. Gonzales G.C., Caamo D.L., Schryvers A.B. Identification and characterisation of a porcine-specific transferring receptor in Actinobacillus pleuropneumoniae. Mol. Microbiol. 4:1990;1173-1179.
29. Griffiths, E., Williams, P., 1999. The iron-uptake systems of pathogenic bacteria, fungi and protozoa. In: Bullen, J.J., Griffiths, E. (Eds.), Iron and Infection: Molecular, Physiological and Clinical Aspects. second ed. Wiley, Chichester, pp. 87-212.
30. Grossmann J.G., Neu M., Pantos E., Schwab F.J., Evans R.W., Townes-Andrews E., Appel H., Thies W.G., Hasnain S.S. X-ray solution scattering reveals conformational changes upon iron uptake in lactoferrin, serum, and ovo-transferrins. J. Mol. Biol. 225:1992;811-819.
31. Groves M.L. The isolation of a red protein from milk. J. Am. Chem. Soc. 82:1960;3345-3350.
32. Hancock R.E.W. Peptide antibiotics. Lancet. 349:1997;418-422.
33. Hancock R.E.W., Lehrer R. Cationic peptides: a new source of antibiotics. TIB. TECH. 16:1998;82-88.
34. Hancock R.E.W., Chapple D.S. Antibiotic peptides. Antimicrob Agents Chemo. 43:1999;215-220.
35. Hancock R.E.W., Diamond G. Cationic antimicrobial peptides: a major element in mammalian innate immune defences against infection. Trends Microbiol. 8:2000;402-410.
36. Hancock R.E.W., Raffle V.J., Nicas T.I. Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 19:1981;777-785.
37. Herrington D.A., Sparling P.E. Haemophilus influenzea can use human transferrin as a sole source of required iron. Infect. Immun. 48:1985;248-251.
38. Hoek K.S., Milne J.M., Grieve P.A., Dionysius D.A., Smith R. Antibacterial activity in bovine lactoferrin-derived peptides. Antimicrob. Agents Chemother. 41:1997;54-59.
39. Houghten R.A., Pinilla C., Blondelle S.E., Appel J.R., Dooley C.T., Cuervo J.H. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature. 354:1991;85-86.
40. Hovanessian A.G., Awdeh Z.L. Gel isoelectric focussing of human serum transferrin. Eur. J. Biochem. 68:1976;333-338.
41. Hwang P.M., Zhou N., Shan X., Arrowsmith C.H., Vogel H.J. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry. 37:1998;4288-4298.
42. Ikeda M., Sugiyama K., Tanaka T., Sekihara H., Shimotohno K., Kato N. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem. Biophys. Res. Commun. 245:1998;253-549.
43. Johansson B.G. Isolation of an iron-containing red protein from human milk. Acta Chem. Scand. 14:1960;510-512.
44. Kalmar J.R., Arnold R.R. Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infect. Immun. 56:1988;2552-2557.
45. Kang J.H., Lee M.K., Kim K.L., Hahan K.S. Structure-biological activity relationship of 11-residue highly basic peptide segment of bovine lactoferrin. Int. J. Pep. Prot. Res. 48:1996;357-363.
46. Kirkpatrick C.H., Green I., Rich R.R., Schade A.L. Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis. J. Infect. Dis. 124:1971;539-544.
47. Kuipers M.E., de Vries H.G., Eikelboom M.C., Meijer D.K.F., Swart P.J. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob. Agents Chemother. 43:1999;2635-2641.
48. Labischinski H., Barnickel G., Bradaczek H., Naumann D., Rietschel E.T., Giesbrecht P. High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeability barrier properties of the outer membrane. J. Bacteriol. 162:1985;9-20.
49. Laquerre S., Argnani R., Anderson D.B., Zucchini S., Manservigi R., Glorioso J.C. Heparan sulphate proteoglycan binding by herpes simplex virus type I glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J. Virol. 72:1998;6119-6130.
50. Lassiter M.O., Newsome A.L., Sams L.D., Arnold R.R. Characterization of lactoferrin interaction with Streptococcus mutans. J. Dental Res. 66:1987;480-485.
51. Levay P.F., Viljoen M. Lactoferrin: a general review. Haematologica. 80:1995;252-267.
52. Lewis L.A., Rohde K., Gipson M., Behrens B., Gray E., Toth S.I., Roe B.A., Dyer D.W. Identification and molecular analysis of IbpBA, which encodes the two-component meningococcal lactoferrin receptor. Infect. Immun. 66:1998;3017-3023.
53. Mann D.M., Romm E., Migliorini M. Delineation of glycosaminoglycan-binding site in human inflammatory response protein lactoferrin. J. Biol. Chem. 269:1994;23661-23667.
54. Martin E., Gantz T., Lehrer R. Defensins and other endogenous peptide antibiotics of vertebrates. J. Leukoc. Biol. 58:1995;128-136.
55. Masson P.L., Heremans J.F. Lactoferrin in milk from different species. Comp. Biochem. Physiol. 39B:1971;119-129.
56. Metz-Boutigue M.-H., Jolles J., Mazurier J., Schoentgen F., Legrand D., Spik G., Montreuil J., Jolles P. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur. J. Biochem. 145:1984;659-676.
57. Mihara H., Takahashi Y. Engineering peptides and proteins that undergo alpha-to-beta transitions. (Erratum appears in Curr. Opin. Struct. Biol. 7 (1997) 749). Curr. Opin. Struct. Biol. 7:1997;501-508.
58. Miyata T., Tokunaga R., Yonaya T. Antimicrobial peptides isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II. Chemical structures and biologic activity. J. Biochem. 106:1989;663-668.
59. Moguilevsky N., Retegui L.A., Masson P.L. Comparison of human lactoferrins from milk and neutrophilic leucocytes. Relative molecular mass, isoelectric point, iron-binding properties and uptake by the liver. Biochem. J. 229:1985;353-359.
60. Nikaido H., Nakae T. The outer membrane of Gram-negative bacteria. Adv. Microb. Physio. 20:1979;163-250.
61. Naidu S.S., Arnold R.R. Lactoferrin interaction with Salmonella potentiates antibiotic susceptibility in vitro. Diag. Microbiol. Infect. Dis. 20:1994;69-75.
62. Naidu S.S., Svensson U., Kishore A.R., Naidu A.S. Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium. Antimicrob. Agents Chemother. 37:1993;240-245.
63. Nikaido H., Vaara M. Molecular basis of bactericidal outer membrane permeability. Microbiol. Revs. 49:1985;1-32.
64. Odell E.W., Sarra R., Foxworthy M., Chapple D.S., Evans R.W. Antibacterial activity of peptides homologous to a loop region in human lactoferrin. FEBS Lett. 382:1996;175-178.
65. Omata Y., Satake M., Maeda R., Saito A., Shimazaki K., Yamauchi K., Uzaka Y., Tanabe S., Sarashina T., Mikami T. Reduction of the infectivity of toxiplasma gondii and Eimeria stedai sporozites by treatment with bovine lactoferricin. J. Vet. Med. Sci. 63:2001;187-190.
66. Petterson A., Prinz T., Umar A., Van der Biezen J., Tommassen J. Molecular characterisation of LbpB, the second lactoferrin binding protein of Neisseria menigitidis. Mol. Microbiol. 27:1998;599-610.
67. Pierce A., Colavizza D., Benaissa M., Maes P., Tartar A., Montreuil J., Spik G. Molecular cloning and sequence analysis of bovine lactotransferrin. Eur. J. Biochem. 196:1991;177-184.
68. Rado T.A., Wei X.P., Benz E.J. Jr. Isolation of lactoferrin cDNA from a human myeloid library and expression of mRNA during normal and leukemic myelopoiesis. Blood. 70:1987;989-993.
69. Rey M.W., Woloshuk S.L., deBoer H.A., Pieper F.R. Complete nucleotide sequence of human mammary gland lactoferrin. Nucl. Acids Res. 18:1990;5288.
70. Saito H., Miyakawa H., Tamura Y., Shimamura S., Tomita M. Potent bactericidal activity of bovine lactoferrin hydrolysate produced by heat treatment at acidic pH. J. Dairy Sci. 74:1991;3724-3730.
71. Sanchez L., Calvo M., Brock J.H. Biological role of lactoferrin. Arch. Dis. Child. 67:1992;657-661.
72. Schibli D.J., Hwang P.M., Vogel H.J. The structure of the antimicrobial active centre of lactoferricin B bound to sodium dodecyl sulfate micelles. FEBS Lett. 446:1999;213-217.
73. Shai Y. Mechanism of the binding, insertion and destabilization of the phospholipid bilayer membrane by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta. 1462:1999;55-70.
74. Smit J., Kamio Y., Nikaido H. Outer membrane of Salmonella typhimurium: chemical analysis and freeze-fracture studies with lipopolysaccharide mutants. J. Bacteriol. 124:1975;942-958.
75. Tachezy J., Kulda J., Bahnikova I., Suchan P., Razga J., Schrevel J. Trichomonus foetus: iron acquisition from lactoferrin and transferrin. Exp. Parasitol. 83:1996;216-228.
76. Tam, J.P., Lu, Y., Yang, J., Yu, Q., 2001, Cyclic cystine-knot - stranded antimicrobial peptides: occurrence, design and synthesis. In: Development of Novel Antimicrobial Agents: Emerging Strategies. Horizon Scientific Press.
77. Tomita M., Takase M., Bellamy W., Shimamura S. A review: the active peptide of lactoferrin. Acta Paediatrica Japonica. 36:1994;585-591.
78. Wakabayashi H., Abe S., Okutomi T., Tansho S., Kawase K., Yamaguchi H. Cooperative anti-Candida effects of lactoferrin or its peptides in cxombination with azole antifungal agents. Microbiol. Immunol. 40:1996;821-825.
79. Wakabayashi H., Abe S., Teraguchi S., Hayasawa H., Yamaguchi H. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob. Agents Chemother. 42:1998;1587-1591.
80. Williams J. The evolution of transferrins. TIBS. 7:1982;394-397.
81. Wimley W.C., White S.H. Experimental determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3:1996;842-848.
82. Yamauchi K., Tomita M., Giehl T.J., Ellison R.T. III Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 61:1993;719-728.
83. Yi M., Kaneko S., Yu D.Y., Murakumi S. Hepatitis C virus envelope proteins bind lactoferrin. J. Virol. 71:1997;5997-6002.